Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.

@article{Romanowski2003PatientsPO,
  title={Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.},
  author={Barbara Romanowski and Raymond B Marina and Jeremy N Roberts},
  journal={Sexually transmitted diseases},
  year={2003},
  volume={30 3},
  pages={
          226-31
        }
}
BACKGROUND Valacyclovir is effective for suppressive and episodic treatment of recurrent genital herpes. Few data on patients' treatment strategy preferences are available. GOAL The goal was to assess patients' preference, satisfaction, and quality of life with suppressive versus episodic treatment of recurrent genital herpes. STUDY DESIGN This was a multicenter, open-label, randomized, two-arm, crossover 48-week study involving 225 patients with genital herpes. RESULTS Suppressive… CONTINUE READING
Highly Cited
This paper has 40 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Sexually transmitted diseases treatment guidelines, 2015.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports • 2015

Sexually transmitted diseases treatment guidelines, 2010.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports • 2010
View 1 Excerpt